Please use this identifier to cite or link to this item:
Title: Counterfeit medicines
Authors: Zammit, Anthia
Keywords: Pharmaceutical industry -- Corrupt practices
Product counterfeiting
Drug adulteration
Issue Date: 2009-11
Publisher: Medical Portals Ltd.
Citation: Zammit, A. (2009). Counterfeit medicines. The Synapse : the Medical Professionals' Network, 6, 6-22.
Abstract: The counterfeiting of medicinal products is a growing concern for patients, the pharmaceutical industry and national policy-makers worldwide. EU internal market rules for medicinal products for human use coupled by wide-ranging International cooperation, and proposed European legislative reforms are hoped to have a positive impact against the problem of counterfeit medicines - one of the greatest current threats to public health and safety.
Appears in Collections:The Synapse, Issue 06/09
The Synapse, Issue 06/09

Files in This Item:
File Description SizeFormat 
The_Synapse,_6-09_-_A3.pdf1.91 MBAdobe PDFView/Open

Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.